India Allergy Diagnostics And Therapeutics Market Size & Outlook
Related Markets
India allergy diagnostics and therapeutics market highlights
- The India allergy diagnostics and therapeutics market generated a revenue of USD 402.4 million in 2024 and is expected to reach USD 857.4 million by 2033.
- The India market is expected to grow at a CAGR of 8.7% from 2025 to 2033.
- In terms of segment, therapeutics was the largest revenue generating type in 2024.
- Diagnostics is the most lucrative type segment registering the fastest growth during the forecast period.
Allergy diagnostics and therapeutics market data book summary
| Market revenue in 2024 | USD 402.4 million |
| Market revenue in 2033 | USD 857.4 million |
| Growth rate | 8.7% (CAGR from 2025 to 2033) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, India accounted for 1.2% of the global allergy diagnostics and therapeutics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan allergy diagnostics and therapeutics market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 857.4 million by 2033.
Therapeutics was the largest segment with a revenue share of 73.14% in 2024. Horizon Databook has segmented the India allergy diagnostics and therapeutics market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
The allergy diagnostics and therapeutics market in India is projected to grow over the forecast period due to improving healthcare infrastructure, rising investments by the government and key players for the development of novel drugs & IVD, and increasing expansion of the pharmaceutical sector in the country. For instance, in June 2020, Cadila Pharma launched an anti-allergic drug, Bilastine, in India.
It introduced Bilastine syrup (30 ml) and Bilastine tablets in the strength of 20mg. It is an antihistamine drug that is used in the treatment of allergic rhinitis. Furthermore, the rising population has increased the incidence of various allergic respiratory diseases such as asthma, childhood asthma, and chronic cough, thus positively impacting the market. Some of the key players in the market are Thermo Fisher Scientific, Inc., Danaher, and Sanofi.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Omega Healthcare Investors Inc | View profile | 53 | 303 International Circle, Suite 200, Hunt Valley, MD, United States, 21030 | https://www.omegahealthcare.com |
| Allergy Therapeutics PLC | View profile | 612 | Dominion Way, Worthing, West Sussex, United Kingdom, BN14 8SA | https://www.allergytherapeutics.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Rohm Co Ltd | View profile | 23751 | 21, Saiin Mizosaki-cho, Ukyo-ku, Kyoto, Japan, 615-8585 | http://www.rohm.co.jp |
| Epigenomics AG | View profile | 18 | Geneststrasse 5, Berlin, BB, Germany, 10829 | https://www.epigenomics.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Alcon Inc | View profile | 25315 | Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, Switzerland, 1214 | https://www.alcon.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
India allergy diagnostics and therapeutics market size, by type, 2021-2033 (US$M)
India Allergy Diagnostics And Therapeutics Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
